Ubiquitin-conjugating enzyme E2 N mRNA 3′ untranslated region (UBE2N mRNA 3′UTR)

The Ubiquitin-conjugating enzyme E2 N (UBE2N) mRNA 3′ untranslated region (3′UTR) is a critical regulatory segment of the UBE2N transcript, which encodes a key enzyme responsible for synthesizing non-canonical Lys-63-linked polyubiquitin chains. This region contains multiple binding sites for microRNAs (miRNAs) and RNA-binding proteins that dictate the stability and translational efficiency of the UBE2N message. UBE2N itself plays a pivotal role in diverse cellular processes, including DNA damage repair, inflammatory signaling via the NF-κB pathway, and protein trafficking. Dysregulation of UBE2N expression, often mediated by alterations in its 3′UTR-dependent control, is associated with the progression of various malignancies, such as lung adenocarcinoma and breast cancer, as well as autoimmune disorders. Therapeutic strategies targeting this specific mRNA region include antisense oligonucleotides (ASOs) and miRNA mimics designed to modulate UBE2N protein levels by interfering with regulatory element interactions. By controlling UBE2N at the post-transcriptional level, these interventions aim to suppress oncogenic signaling and restore normal cellular homeostasis.

Other names

UBE2N 3′UTRUBC13 mRNA 3′UTRUbiquitin-conjugating enzyme E2 N 3′ untranslated regionUBC13 3′UTR

The UBE2N mRNA 3′UTR is targeted primarily through antisense mechanisms, RNA interference (RNAi), or microRNA (miRNA) mimics that bind to complementary sequences within the region to induce mRNA degradation or inhibit translation. By reducing the levels of UBE2N mRNA and its subsequent protein product, these interventions disrupt the formation of Lys-63-linked polyubiquitin chains, thereby modulating oncogenic and inflammatory signaling pathways.